« FDA approves Actemra to treat rare form of juvenile arthritis | Main | FDA Approvals - Provectus Receives Orphan Drug Designation From FDA For The Treatment »

FDA approves Horizant to treat restless legs syndrome On April


FDA approves Horizant to treat restless legs syndrome
On April 6, the U.S. Food and Drug Administration approved Horizant Extended Release Tablets (gabapentin enacarbil), a once-daily treatment for moderate-to-severe restless legs syndrome (RLS).
 

©2006 FDA-News.com. All rights reserved.